Browse CATs

Browse CATs  internal medicine  neurology  stroke

Diagnosis Economics Harm/ aetiology Prognosis Therapy Rehabilitation Other therapies

Antiplatelet therapy reduces deaths, strokes, MI. Level of evidence 1a Expiry Date July 2003 Atrial fibrillation warfarin reduces the risk of stroke and death. Level of evidence 1a Expiry Date June 2003 Hypertension diuretics, beta-blockers and ACE inhibitors decrease death. Level of evidence 1a Expiry Date January 2002 Hypertension in elderly patients, beta-blockers are less effective as first-line therapy than diuretics. Level of evidence 1a Expiry Date July 2003 Stroke ticlopidine decreased the risk of stroke. Level of evidence 1b Expiry Date December 2002 Stroke aspirin decreases recurrent stroke. Level of evidence 1a Expiry Date January 2003 Stroke low-dose acetylsalicylic acid decreased stroke, MI and death. Level of evidence 1b Expiry Date November 2002 Stroke antihypertensives decrease recurrent stroke. Level of evidence 1a Expiry Date December 2002 Stroke anticoagulants decrease deep venous thrombosis. Level of evidence 1a Expiry Date June 2003 Stroke tissue plasminogen activator had no clear effect. Level of evidence 1b- Expiry Date December 2002 Stroke statin monotherapy decreases secondary stroke. Level of evidence 1a Expiry Date November 2002 Stroke early aspirin decreased death. Level of evidence 1b Expiry Date November 2002 Stroke different doses of thrombolytics and agents had no clear effect on death. Level of evidence 1a- Expiry Date December 2002 Stroke thrombolytics decrease death and dependency. Level of evidence 1a Expiry Date December 2002 Stroke statin drugs decrease stroke and death. Level of evidence 1a Expiry Date November 2002 Stroke neither aspirin or heparin clearly reduced death or dependency. Level of evidence 1b- Expiry Date November 2002 Stroke dipyridamole with aspirin was better than aspirin alone. Level of evidence 1b Expiry Date October 2002 Stroke clopidogrel decreased any stroke, MI or death compared with aspirin. Level of evidence 1b Expiry Date November 2002 Stroke stroke units increase discharge home. Level of evidence 1b Expiry Date February 2003 Stroke thrombolytics decrease death and dependency. Level of evidence 1a Expiry Date December 2002 Stroke anticoagulants are better than aspirin at preventing vascular events. Level of evidence 1a Expiry Date October 2002 Stroke Alteplase had no clear effect on combined favourable outcomes, but may improve independence. Level of evidence 1b Expiry Date December 2002 Stroke Ticlodipine decreases stroke, MI or vascular death. Level of evidence 1b Expiry Date December 2002 Stroke clopidogrel decreased any stroke, MI or death compared with aspirin. Level of evidence 1b Expiry Date November 2002 Stroke indobufen was not clearly better than warfarin. Level of evidence 1b- Expiry Date October 2002 Stroke or TIA perindopril and indapamide reduced stroke and major vascular events. Level of evidence 1b Expiry Date October 2003